2024
Assessment of the BNT162B2 COVID-19 vaccine immune response in Brazilian indigenous adolescents
de Oliveira L, de Morais I, Marchioro S, de Almeida G, de Almeida de Souza G, da Silva Ferreira T, Rossoni R, de Oliveira Barbosa D, Navarini V, Croda J, Torres A, Simionatto S. Assessment of the BNT162B2 COVID-19 vaccine immune response in Brazilian indigenous adolescents. Vaccine 2024, 43: 126494. PMID: 39571350, DOI: 10.1016/j.vaccine.2024.126494.Peer-Reviewed Original ResearchCD8+ T cellsBNT162b2 vaccineT cellsB lymphocytesIncreased levels of B lymphocytesImmune responseCell subpopulationsLevels of B lymphocytesSARS-CoV-2-specific immune responsesMemory B cellsNon-classical monocytesIndigenous adolescentsStatistically significant increaseNK cellsVaccinated adolescentsB cellsNo significant changesBooster doseCohort studyBNT162b2Vaccination scheduleLimited healthcare resourcesImmunogenic responseDemographic dataCOVID-19 vaccine
2010
Characterization of cytotoxic immune response in skin and mucosal lesions of paracoccidioidomycosis
Pagliari C, Pereira N, Kanashiro L, Stegun F, Croda J, Duarte M, Sotto M. Characterization of cytotoxic immune response in skin and mucosal lesions of paracoccidioidomycosis. Journal Of Cutaneous Pathology 2010, 37: 565-570. PMID: 19702683, DOI: 10.1111/j.1600-0560.2009.01413.x.Peer-Reviewed Original ResearchConceptsNK cellsT cellsMucosal lesionsImmune responseGranzyme BPredominance of CD8Granzyme B expressionNatural killer cellsCytotoxic immune responseNumber of granzymeKiller cellsG3 lesionsCD8G2 lesionsSuch lesionsCompact granulomasLesionsB expressionSame lesionGranulomasMucosaPerforinSkinSuch cellsCells